Open this publication in new window or tab >>Department of Pediatric Endocrinology, University Children's Hospital, Tübingen, Germany.
Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland.
Department of Pediatric Endocrinoly and Diabetes, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Israel and Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Department of Paediatrics, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Research institute ‘Amsterdam Gastroenterology Endocrinoly Metabolism’, Amsterdam, Netherlands; Research institute ‘Amsterdam Reproduction and Development’, Amsterdam, Netherlands.
Department of Growth and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Paediatrics.
Diabeter, Center for Pediatric and Adult Diabetes Care and Research, Rotterdam, Netherlands; Department of Pediatric Endocrinology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, Netherlands.
Department of Pediatrics and Pediatric Endocrinology, Maastricht University Medical Center, Netherlands.
Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Netherlands.
Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland.
Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, Netherlands.
Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, Netherlands.
Department of Reproductive Medicine, Nij Geertgen Center for Fertility, Elsendorp, Netherlands.
Department of Laboratory Medicine, Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands.
Department of Paediatrics, Radboud University Medical Center, Amalia Children's Hospital, Nijmegen, Netherlands.
Show others...
2025 (English)In: Fertility and Sterility, ISSN 0015-0282, E-ISSN 1556-5653, Vol. 124, no 6, p. 1314-1323Article in journal (Refereed) Published
Abstract [en]
Objective: To study reproductive hormone levels during minipuberty in girls with Turner syndrome and compare with girls without Turner syndrome.
Design: Prospective cohort study.
Subjects: Infant girls with Turner syndrome.
Exposure: Blood samples were drawn at 3 and 9 months of age for analysis of reproductive hormones. Karyotype was analyzed in 30 lymphocytes and, if available, in 100 buccal cells. Hormone levels in girls with Turner syndrome were compared with reference values of a control group.
Main Outcome Measures: Follicle-stimulating hormone, luteinizing hormone, estradiol, antimüllerian (AMH), inhibin B, and testosterone levels.
Results: Fourteen girls with 45,X; five girls with 45,X/46,XX; and four girls with a structural aberration of the X chromosome were included. Follicle-stimulating hormone and luteinizing hormone levels were significantly higher, and estradiol, AMH, and inhibin B levels were significantly lower in girls with Turner syndrome compared with reference values at both time points. In girls with Turner syndrome with undetectable AMH levels, gonadotropin levels increased after 3 months, whereas in girls with Turner syndrome with detectable AMH levels, gonadotropin levels decreased after 3 months to levels within the reference range.
Conclusion: Hypothalamus-pituitary-gonadal axis hormone levels during minipuberty in girls with Turner syndrome differ from reference values. The window for assessing ovarian function extends beyond 3 months of age because gonadotropin levels tend to increase in cases with absent ovarian activity, as demonstrated by undetectable AMH, inhibin B, and estradiol levels.
Place, publisher, year, edition, pages
Elsevier, 2025
Keywords
fertility preservation, minipuberty, reproductive hormones, Turner syndrome
National Category
Gynaecology, Obstetrics and Reproductive Medicine
Identifiers
urn:nbn:se:umu:diva-243412 (URN)10.1016/j.fertnstert.2025.07.003 (DOI)40651522 (PubMedID)2-s2.0-105012862714 (Scopus ID)
2025-08-252025-08-252025-12-11Bibliographically approved